Compounded Tirzepatide Cost: A 36-Provider Price Snapshot

In a snapshot taken in October 2026, 36 provider records with a price-read date and an unqualified monthly tirzepatide price ranged from $109 to $715. The median was $232. This describes a defined subset of our records, not every seller or a guarantee of today's checkout price.

How we built this comparison

We included only records with a recorded price-read date and a tirzepatide field in the simple form “$N/mo.” We excluded “from” prices, annual averages, introduction-and-renewal ladders, microdose offers, and undated records. The underlying reads span August through October 2026. We did not recheck all 36 sellers on publication day.

This filter makes the arithmetic reproducible, but has limits. A plain monthly field does not prove that every dose is included or every ancillary fee is zero. We use it as a price snapshot, not as a claim that the plans are clinically or legally interchangeable.

Where the listed prices fall

The median is the average of the eighteenth and nineteenth observations in the sorted 36-record sample, $229 and $235: $232. It is not the average bill across actual patients. At $232 for twelve unchanged monthly charges, the arithmetic is $2,784; dose changes, renewal terms, and service fees can change the real total.

Examples with the read date attached

Read CoreAge Rx's review, Eden's review, and Ondra Health's review for context beyond the price field. This is not a cheapest-provider endorsement. Confirm each provider's current public terms and dispensing pharmacy before committing.

Why a lower headline can cost more

An annual plan at $149 a month might require $1,788 immediately. A first month at $149 followed by eleven months at $299 totals $3,438. A $249 charge every four weeks produces thirteen charges in 52 weeks, or $3,237. Those illustrative examples describe billing structures, not a particular provider. For a real commitment comparison, the Amble tirzepatide review separates its $329 single-month offer from $255 and $235 monthly equivalents on three- and six-month plans, and explains why sending an order to the pharmacy can end refund eligibility before shipping.

Ask for the actual charge, billing interval, minimum term, refund rules, dose tiers, and renewal price. Keep membership, consultation, labs, and shipping on separate lines. Our structured medication-price records do not capture every one of those charges; an unrecorded fee must not be treated as zero.

Compare an approved option too

Lilly's Zepbound self-pay route offers a starting-dose benchmark of $299, a 5 mg price of $399, and eligible higher-dose prices of $449 under the Journey program.¹ The KwikPen and vial guide explains the current device and refill rules. A compounded price should be compared with the approved product at a relevant dose and supply duration, not its list price alone.

Compounded tirzepatide is not FDA-approved. FDA's concerns include dosing, quality, and misleading claims; a seller's low price does not establish that its prescription meets compounding law.² Read current compounding rules and ask the prescriber to explain your particular formulation.

Turn the snapshot into a personal budget

Use the tirzepatide board to find service descriptions, then the cost calculator to compare the recorded medication commitments. Confirm the final numbers with the provider. Our broader compounded GLP-1 cost guide explains the different billing patterns across semaglutide and tirzepatide.

Use the billing-cycle calculator when a refill repeats every four weeks. The Big Easy review explains why a 12-week package needs a different comparison from a monthly subscription, while the FitFlow review separates an annual prepaid equivalent from monthly billing.